BrightSpring Health Services is a home and community-based healthcare platform serving medically complex patients — primarily seniors and people with behavioral conditions — through two segments: Pharmacy Solutions (~87% of revenue) and Provider Services (~13%). The company serves over 465,000 patients daily across all 50 states, with Medicare, Medicaid, and managed care organizations as the primary payors. Pharmacy Solutions has two core businesses: Infusion and Specialty Pharmacy, which distributes high-cost drugs for oncology, rare diseases, and auto-immune conditions, and Home and Community Pharmacy, which handles daily medication dispensing and delivery to patients in assisted living, group homes, hospice, and home settings. A key driver in specialty pharmacy is BrightSpring's portfolio of limited distribution drugs (LDDs) — therapies where manufacturers select only a small number of pharmacies to distribute and clinically support their products. BrightSpring holds 145 LDDs through its Onco360 and CareMed businesses. Provider Services includes home health and hospice, rehab care, and personal care. BrightSpring is reimbursed on a fee-for-service basis, and is also divesting its Community Living business for $835M to sharpen its focus. Growth is driven by new LDD launches, generic drug conversions in oncology, home health and hospice expansion, and tuck-in M&A. BrightSpring also argues that integrating pharmacy and clinical care for the same patients is a differentiator, enabling cross-selling and positioning the company for value-based care contracting.